Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-01

Clinical Trial Update: The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the impact of epoetin alfa on cardiac function and quality of life in patients with anemia and early chronic kidney disease; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Janssen-Cilag B.V. | Conditions: Anemia | Phase 3 | Status: COMPLETED